Biopharmaceutical CMO and CRO Market (By Source: Mammalian, Non-mammalian; By Service Type: Contract Manufacturing, Contract Research; By Product: Biologics, Biosimilars) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2022 – 2030

Published Date : Jan 2022 | No. of Pages : 150+ Pages | Category : Healthcare


Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Biopharmaceutical CMO and CRO Market, By Source

7.1.  Biopharmaceutical CMO and CRO Market, by Source, 2021-2030

7.1.1.    Mammalian

7.1.1.1.        Market Revenue and Forecast (2017-2030)

7.1.2.    Non-mammalian

7.1.2.1.        Market Revenue and Forecast (2017-2030)

Chapter 8.  Global Biopharmaceutical CMO and CRO Market, By Service Type

8.1.  Biopharmaceutical CMO and CRO Market, by Service Type, 2021-2030

8.1.1.    Contract Manufacturing

8.1.1.1.        Market Revenue and Forecast (2017-2030)

8.1.2.    Contract Research

8.1.2.1.        Market Revenue and Forecast (2017-2030)

Chapter 9.  Global Biopharmaceutical CMO and CRO Market, By Product

9.1.  Biopharmaceutical CMO and CRO Market, by Product, 2021-2030

9.1.1.    Biologics

9.1.1.1.        Market Revenue and Forecast (2017-2030)

9.1.2.    Biosimilars

9.1.2.1.        Market Revenue and Forecast (2017-2030)

Chapter 10.      Global Biopharmaceutical CMO and CRO Market, Regional Estimates and Trend Forecast

10.1.        North America

10.1.1.  Market Revenue and Forecast, by Source (2017-2030)

10.1.2.  Market Revenue and Forecast, by Service Type (2017-2030)

10.1.3.  Market Revenue and Forecast, by Product (2017-2030)

10.1.4.  U.S.

10.1.4.1.      Market Revenue and Forecast, by Source (2017-2030)

10.1.4.2.      Market Revenue and Forecast, by Service Type (2017-2030)

10.1.4.3.      Market Revenue and Forecast, by Product (2017-2030)

10.1.5.  Rest of North America

10.1.5.1.      Market Revenue and Forecast, by Source (2017-2030)

10.1.5.2.      Market Revenue and Forecast, by Service Type (2017-2030)

10.1.5.3.      Market Revenue and Forecast, by Product (2017-2030)

10.2.        Europe

10.2.1.  Market Revenue and Forecast, by Source (2017-2030)

10.2.2.  Market Revenue and Forecast, by Service Type (2017-2030)

10.2.3.  Market Revenue and Forecast, by Product (2017-2030)

10.2.4.  UK

10.2.4.1.      Market Revenue and Forecast, by Source (2017-2030)

10.2.4.2.      Market Revenue and Forecast, by Service Type (2017-2030)

10.2.4.3.      Market Revenue and Forecast, by Product (2017-2030)

10.2.5.  Germany

10.2.5.1.      Market Revenue and Forecast, by Source (2017-2030)

10.2.5.2.      Market Revenue and Forecast, by Service Type (2017-2030)

10.2.5.3.      Market Revenue and Forecast, by Product (2017-2030)

10.2.6.  France

10.2.6.1.      Market Revenue and Forecast, by Source (2017-2030)

10.2.6.2.      Market Revenue and Forecast, by Service Type (2017-2030)

10.2.6.3.      Market Revenue and Forecast, by Product (2017-2030)

10.2.7.  Rest of Europe

10.2.7.1.      Market Revenue and Forecast, by Source (2017-2030)

10.2.7.2.      Market Revenue and Forecast, by Service Type (2017-2030)

10.2.7.3.      Market Revenue and Forecast, by Product (2017-2030)

10.3.        APAC

10.3.1.  Market Revenue and Forecast, by Source (2017-2030)

10.3.2.  Market Revenue and Forecast, by Service Type (2017-2030)

10.3.3.  Market Revenue and Forecast, by Product (2017-2030)

10.3.4.  India

10.3.4.1.      Market Revenue and Forecast, by Source (2017-2030)

10.3.4.2.      Market Revenue and Forecast, by Service Type (2017-2030)

10.3.4.3.      Market Revenue and Forecast, by Product (2017-2030)

10.3.5.  China

10.3.5.1.      Market Revenue and Forecast, by Source (2017-2030)

10.3.5.2.      Market Revenue and Forecast, by Service Type (2017-2030)

10.3.5.3.      Market Revenue and Forecast, by Product (2017-2030)

10.3.6.  Japan

10.3.6.1.      Market Revenue and Forecast, by Source (2017-2030)

10.3.6.2.      Market Revenue and Forecast, by Service Type (2017-2030)

10.3.6.3.      Market Revenue and Forecast, by Product (2017-2030)

10.3.7.  Rest of APAC

10.3.7.1.      Market Revenue and Forecast, by Source (2017-2030)

10.3.7.2.      Market Revenue and Forecast, by Service Type (2017-2030)

10.3.7.3.      Market Revenue and Forecast, by Product (2017-2030)

10.4.        MEA

10.4.1.  Market Revenue and Forecast, by Source (2017-2030)

10.4.2.  Market Revenue and Forecast, by Service Type (2017-2030)

10.4.3.  Market Revenue and Forecast, by Product (2017-2030)

10.4.4.  GCC

10.4.4.1.      Market Revenue and Forecast, by Source (2017-2030)

10.4.4.2.      Market Revenue and Forecast, by Service Type (2017-2030)

10.4.4.3.      Market Revenue and Forecast, by Product (2017-2030)

10.4.5.  North Africa

10.4.5.1.      Market Revenue and Forecast, by Source (2017-2030)

10.4.5.2.      Market Revenue and Forecast, by Service Type (2017-2030)

10.4.5.3.      Market Revenue and Forecast, by Product (2017-2030)

10.4.6.  South Africa

10.4.6.1.      Market Revenue and Forecast, by Source (2017-2030)

10.4.6.2.      Market Revenue and Forecast, by Service Type (2017-2030)

10.4.6.3.      Market Revenue and Forecast, by Product (2017-2030)

10.4.7.  Rest of MEA

10.4.7.1.      Market Revenue and Forecast, by Source (2017-2030)

10.4.7.2.      Market Revenue and Forecast, by Service Type (2017-2030)

10.4.7.3.      Market Revenue and Forecast, by Product (2017-2030)

10.5.        Latin America

10.5.1.  Market Revenue and Forecast, by Source (2017-2030)

10.5.2.  Market Revenue and Forecast, by Service Type (2017-2030)

10.5.3.  Market Revenue and Forecast, by Product (2017-2030)

10.5.4.  Brazil

10.5.4.1.      Market Revenue and Forecast, by Source (2017-2030)

10.5.4.2.      Market Revenue and Forecast, by Service Type (2017-2030)

10.5.4.3.      Market Revenue and Forecast, by Product (2017-2030)

10.5.5.  Rest of LATAM

10.5.5.1.      Market Revenue and Forecast, by Source (2017-2030)

10.5.5.2.      Market Revenue and Forecast, by Service Type (2017-2030)

10.5.5.3.      Market Revenue and Forecast, by Product (2017-2030)

Chapter 11.  Company Profiles

11.1.              Boehringer Ingelheim GmbH

11.1.1.  Company Overview

11.1.2.  Product Offerings

11.1.3.  Financial Performance

11.1.4.  Recent Initiatives

11.2.              Lonza Group AG

11.2.1.  Company Overview

11.2.2.  Product Offerings

11.2.3.  Financial Performance

11.2.4.  Recent Initiatives

11.3.              Inno Biologics Sdn Bhd

11.3.1.  Company Overview

11.3.2.  Product Offerings

11.3.3.  Financial Performance

11.3.4.  Recent Initiatives

11.4.              Rentschler Biopharma SE

11.4.1.  Company Overview

11.4.2.  Product Offerings

11.4.3.  Financial Performance

11.4.4.  Recent Initiatives

11.5.              JRS Pharma

11.5.1.  Company Overview

11.5.2.  Product Offerings

11.5.3.  Financial Performance

11.5.4.  Recent Initiatives

11.6.              Biomeva GmbH

11.6.1.  Company Overview

11.6.2.  Product Offerings

11.6.3.  Financial Performance

11.6.4.  Recent Initiatives

11.7.              ProBioGen AG

11.7.1.  Company Overview

11.7.2.  Product Offerings

11.7.3.  Financial Performance

11.7.4.  Recent Initiatives

11.8.              Fujifilm Diosynth Biotechnologies U.S.A., Inc.

11.8.1.  Company Overview

11.8.2.  Product Offerings

11.8.3.  Financial Performance

11.8.4.  Recent Initiatives

11.9.              Toyobo Co., Ltd.

11.9.1.  Company Overview

11.9.2.  Product Offerings

11.9.3.  Financial Performance

11.9.4.  Recent Initiatives

11.10.           Samsung Biologics

11.10.1.               Company Overview

11.10.2.               Product Offerings

11.10.3.               Financial Performance

11.10.4.               Recent Initiatives

Chapter 12.  Research Methodology

12.1.              Primary Research

12.2.              Secondary Research

12.3.              Assumptions

Chapter 13.  Appendix

13.1.              About Us

13.2.              Glossary of Terms

Featured Research Reports

  • Featured Research Reports

    U.S. Virtual Visits Market (By Service Type: Cold & Flu management, Allergies, Urgent Care, Preventive Care, Chronic Care Management, Behavioural Health ; By Commercial Plan Type: Small Group, Self-Funded/ASO Group Plans, Medicaid, Medicare, By Age Group, By Gender)- Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

    Read more...
  • Featured Research Reports

    Next-Generation Sequencing Services Market (By Service Type: Human Genome Sequencing, Gene Regulation Services; By Workflow: Pre-sequencing, Sequencing, Data Analysis; By End-use)- Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

    Read more...
  • Featured Research Reports

    Pediatric Clinical Trials Market (By Phase: Phase II, IV; By Study Design: Treatment, Observational Studies; By Therapeutic Areas: Mental Health Disorders, Oncology)- Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

    Read more...
  • Featured Research Reports

    Medical Digital Imaging Systems Market (By Type: X-ray, MRI, Ultrasound, CT, Nuclear Imaging; By Technology: 2D, 3D/4D) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

    Read more...
  • Featured Research Reports

    U.S. Pharmacy Benefit Management Market (By Business Model: Standalone, Health Insurance Providers, Retail Pharmacy; By End Use: Commercial, Federal) - Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

    Read more...